MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 97 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $118,000 | +110.7% | 46,734 | +71.0% | 0.00% | – |
| Q1 2020 | $56,000 | -49.5% | 27,329 | -46.9% | 0.00% | – |
| Q4 2019 | $111,000 | +22.0% | 51,468 | -12.8% | 0.00% | – |
| Q3 2019 | $91,000 | -32.1% | 59,031 | +82.5% | 0.00% | – |
| Q2 2019 | $134,000 | +139.3% | 32,351 | +142.6% | 0.00% | – |
| Q1 2019 | $56,000 | -1.8% | 13,336 | -33.3% | 0.00% | – |
| Q4 2018 | $57,000 | -90.3% | 20,000 | -65.8% | 0.00% | – |
| Q3 2018 | $585,000 | +75.7% | 58,556 | +24.4% | 0.00% | – |
| Q2 2018 | $333,000 | +43.5% | 47,057 | -22.2% | 0.00% | – |
| Q1 2018 | $232,000 | – | 60,501 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,042,735 | $21,079,000 | 8.43% |
| VHCP Management III, LLC | 1,258,964 | $5,262,000 | 3.07% |
| Granite Point Capital Management, L.P. | 3,045,407 | $12,730,000 | 1.23% |
| VHCP Management II, LLC | 743,876 | $3,109,000 | 0.91% |
| Endurant Capital Management LP | 437,299 | $1,828,000 | 0.72% |
| 683 Capital Management, LLC | 1,400,000 | $5,852,000 | 0.53% |
| Granite Point Capital Management, L.P. | 800,000 | $3,344,000 | 0.32% |
| Fosun International Ltd | 390,860 | $1,540,000 | 0.10% |
| Caption Management, LLC | 250,000 | $1,045,000 | 0.06% |
| Tekla Capital Management LLC | 328,436 | $1,373,000 | 0.06% |